| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Lee Tien-Li is a Chief Executive Officer at Aardvark Therapeutics, Inc.. Recent SEC Form 4 filings include 7 buys and 0 sells.
Estimated insider holdings value: $6.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | AARD Aardvark Therapeutics, Inc. | Chief Executive Officer | Buy | 7,000 | $14.49 | $101,395.00 | +0.5% | -66.7% | - | |
| Sep 15, 2025 | AARD Aardvark Therapeutics, Inc. | Chief Executive Officer | Buy | 10,000 | $9.66 | $96,623.60 | +0.3% | +45.4% | - | |
| Sep 12, 2025 | AARD Aardvark Therapeutics, Inc. | Chief Executive Officer | Buy | 20,000 | $8.03 | $160,654.00 | +0.4% | +81.7% | - | |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | Chief Executive Officer | Buy | 16,542 | $16.00 | $264,672.00 | +1.1% | -31.7% | -9.0% |